* APL-130277 for the treatment of off episodes in patients
with Parkinson’s disease
Source text for Eikon:
Further company coverage:
The post BRIEF-Cynapsus provides European clinical update for parkinson’s drug appeared first on NASDAQ.
BRIEF-Cynapsus provides European clinical update for parkinson’s drug
